Treatment Landscape of Targeted Therapies in Oncology: Challenges and Opportunities provides up-to-date knowledge on antitumor-targeted therapies and immunotherapy. The book's chapters are written by researchers dynamically working/focusing on cancer treatment. The content is designed to help those who are new to the field (beginners) and various specialized scientists and researchers involved in cancer research. For decades, the hallmark of cancer treatment has been conventional chemotherapy. But with the rapid increase in our understanding of the immune system, more and more small molecules, peptides, recombinant antibodies, vaccines and cellular therapeutic modalities are being applied to manipulate the immune response for cancer treatment.
1. Treatment Landscape of Targeted Therapies in Oncology - p. i 2. Cover - p. i 3. Title Page - p. iii 4. Copyright - p. iv 5. Table of Contents - p. iv 6. List of Contributors - p. xiii 7. Preface - p. xvii 8. Chapter 1 Biology of cancer: current insights and perspectives - p. 1 9. Chapter 2 Evolution of targeted therapies in cancer: opportunities and challenges - p. 13 10. Chapter 3 Clinical implementation of biomarkers and signaling pathway as novel targeted therapeutics in breast cancer - p. 27 11. Chapter 4 Targeted therapies in advanced lung cancer—current landscapes and future projects - p. 57 12. Chapter 5 Targeted therapies: emerging biomarkers in advanced melanoma - p. 71 13. Chapter 6 Targeting immune checkpoints for cancer therapy - p. 95 14. Chapter 7 Glioblastoma targeted therapies: updated approaches from recent biological insights - p. 135 15. Chapter 8 Current trends and future prospects of molecular targeted therapy in head and neck squamous carcinoma - p. 165 16. Chapter 9 Targeted therapy and drug resistance in gastric and pancreatic cancer - p. 183 17. Chapter 10 Colorectal cancer heterogeneity and targeted therapy: clinical implications, challenges, and solutions for treatment resistance - p. 207 18. Chapter 11 Endometrial cancer: molecular markers and management of advanced-stage disease - p. 223 19. Index - p. 239
Treatment Landscape of Targeted Therapies in Oncology: Challenges and Opportunities provides up-to-date knowledge on antitumor-targeted therapies and immunotherapy. The book's chapters are written by researchers dynamically working/focusing on cancer treatment. The content is designed to help those who are new to the field (beginners) and various specialized scientists and researchers involved in cancer research. For decades, the hallmark of cancer treatment has been conventional chemotherapy. But with the rapid increase in our understanding of the immune system, more and more small molecules, peptides, recombinant antibodies, vaccines and cellular therapeutic modalities are being applied to manipulate the immune response for cancer treatment.
1. Treatment Landscape of Targeted Therapies in Oncology - p. i 2. Cover - p. i 3. Title Page - p. iii 4. Copyright - p. iv 5. Table of Contents - p. iv 6. List of Contributors - p. xiii 7. Preface - p. xvii 8. Chapter 1 Biology of cancer: current insights and perspectives - p. 1 9. Chapter 2 Evolution of targeted therapies in cancer: opportunities and challenges - p. 13 10. Chapter 3 Clinical implementation of biomarkers and signaling pathway as novel targeted therapeutics in breast cancer - p. 27 11. Chapter 4 Targeted therapies in advanced lung cancer—current landscapes and future projects - p. 57 12. Chapter 5 Targeted therapies: emerging biomarkers in advanced melanoma - p. 71 13. Chapter 6 Targeting immune checkpoints for cancer therapy - p. 95 14. Chapter 7 Glioblastoma targeted therapies: updated approaches from recent biological insights - p. 135 15. Chapter 8 Current trends and future prospects of molecular targeted therapy in head and neck squamous carcinoma - p. 165 16. Chapter 9 Targeted therapy and drug resistance in gastric and pancreatic cancer - p. 183 17. Chapter 10 Colorectal cancer heterogeneity and targeted therapy: clinical implications, challenges, and solutions for treatment resistance - p. 207 18. Chapter 11 Endometrial cancer: molecular markers and management of advanced-stage disease - p. 223 19. Index - p. 239
